Zobrazeno 1 - 10
of 51
pro vyhledávání: '"D D Abramov"'
Autor:
I A Guseva, A V Smirnov, N V Demidova, M Yu Krylov, A S Avdeeva, E Yu Samarkina, E L Luchikhina, D E Karateev, D D Abramov, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 90, Iss 5, Pp 38-43 (2018)
Objective. To clarify the association between HLA-DRB1 and TNFα (-308G>A) genes polymorphism and joint destruction/further progression during 12 months of the follow-up period (FUP) in patients with early (
Externí odkaz:
https://doaj.org/article/485938261a6c458aa6c7809045487b63
Autor:
M. B. Khakimova, A. L. Komarov, A. B. Dobrovolsky, E. V. Titaeva, V. V. Kadochnikova, D. D. Abramov, E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 13, Iss 2, Pp 16-27 (2024)
Introduction. Patients undergoing elective myocardial revascularization require 6 months of dual antiplatelet therapy (DAPT), including aspirin and clopidogrel. In patients with multifocal atherosclerotic lesion (MFA), it may be reasonable to extend
Externí odkaz:
https://doaj.org/article/4032d57357514dc6b0b82b1140824a58
Autor:
D D Abramov, Ivan Ivanovich Dedov, D Yu Trofimov, M N Boldyreva, Tamara Leonidovna Kuraeva, L P Alekseev
Publikováno v:
Сахарный диабет, Vol 10, Iss 3, Pp 2-3 (2007)
Цель. Изучение распространения полиморфизма 49A/G гена CTLA4 (rs231775) в русской популяции у больных CД 1 и у здоровых доноров. Материалы и методы.
Externí odkaz:
https://doaj.org/article/9c55be3b482a44308304920132f1f6ea
Autor:
I. A. Guseva, E. L. Luchikhina, N. V. Demidova, A. S. Avdeeva, N. E. Soroka, D. D. Abramov, M. V. Cherkasova, E. Yu. Samarkina, D. E. Karateev, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 1, Pp 28-33 (2018)
Rheumatoid arthritis (RA) is a multifactorial disease, in which the interaction of the genetic component and environmental factors, determines not only the development of the disease, but also its pronounced clinical polymorphism. We assume that the
Externí odkaz:
https://doaj.org/article/0b5b6567e5e34dceb7c2b12fbc36c1b9
Autor:
K. R Dudina, M. M Kutateladze, N. O Bokova, O. O Znoiko, D. D Abramov, E. I Kelly, N. D Yuschuk
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 92, Iss 6, Pp 71-77 (2015)
Aim. Evaluate role of gene polymorphisms of surfactant proteins in susceptibility and severity of influenza infection course in representatives of Moscow population. Materials and methods. 320 influenza patients, infected with various influenza virus
Externí odkaz:
https://doaj.org/article/c8b42c40e41641eaac5f6039130394ba
Autor:
Ye. I. Bateneva, M. G. Filippova, A. S. Tyulyandina, A. A. Meshcheryakov, K. I. Zhordania, A. N. Gritsai, V. V. Kadochnikova, D. D. Abramov, A. A. Ragimov, D. Yu. Trofimov, L. N. Lyubchenko
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 4, Pp 51-56 (2015)
Background. The early diagnosis of ovarian cancer (OC) is an important problem in modern gynecological oncology due to significant detection rates for late-stage tumors. Intensive screening of patients from high-risk groups that include OC predisposi
Externí odkaz:
https://doaj.org/article/5f809c4e1f454fe78097631b53e43207
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 2, Pp 82-86 (2019)
Aim. To determine the qualitative and quantitative composition of the oral microbiota in patients with medial osteonecrosis of the jaw (MOJ). Materials and methods. Microbiota was evaluated in 15 patients with medial osteonecrosis of the jaw. An asse
Autor:
A. I. Nikiforova, S. Yu. Semykin, Moscow Perinatology, A. V. Goriainova, D. Yu. Trofimov, D. D. Abramov, Moscow DNA-Technology Llc, G. U. Zobkova, A E Donnikov, J. Shubina
Publikováno v:
Bulletin of Russian State Medical University. :34-40
Autor:
A.V. Smirnov, E. L. Luchikhina, I A Guseva, A. S. Avdeeva, E. Karateev, N. Demidova, M. Krylov, D D Abramov, Nasonov El, E. Samarkina
Publikováno v:
Rheumatoid arthritis – prognosis, predictors and outcome.
Objectives To clarify the association between HLA-DRB1 and TNFα (−308G>A) genes polymorphism and joint destruction/further progression during 12 months of the follow-up period (FUP) in patients with early ( Methods The study included 85 patients w
Autor:
A.A. Novikov, E. L. Luchikhina, D. Trofimov, I A Guseva, E.N. Alexandrova, E. Samarkina, M. Krylov, D D Abramov, Nasonov El, N. Demidova, D.E. Karateev, A. S. Avdeeva
Publikováno v:
Abstracts Accepted for Publication.
Background Monotherapy with MTX is the first step of RA therapy as recommended by EULAR. According to “Treat to Target” (T2T) strategy principles insufficient response to MTX requires prompt switch to a combination therapy with biological agents.